Literature DB >> 21254797

Modulatory effects of levodopa on cognitive control in young but not in older subjects: a pharmacological fMRI study.

Özgür A Onur1, Martina Piefke, Chuh-Hyoun Lie, Christiane M Thiel, Gereon R Fink.   

Abstract

Older individuals show decline of prefrontal cortex (PFC) functions which may be related to altered dopaminergic neurotransmission. We investigated the effects of aging and dopaminergic stimulation in 15 young and 13 older healthy subjects on the neural correlates of interference control using fMRI. In a double-blind, placebo-controlled within-subject design, subjects were measured after levodopa (100 mg) or placebo administration. In each session, subjects performed a visual-spatial interference task based on a Stroop/Simon-like paradigm. Across age groups, interference (incongruent relative to congruent trials) was associated with activations in the presupplementary motor area, ACC, and intraparietal cortex. Increased interference was found behaviorally in older volunteers. Differential activation in left dorsolateral PFC in young subjects and bilateral PFC activity in older subjects was observed to be associated with interference control. Performance deteriorated under levodopa only in young subjects. This was accompanied by an increase of neural activity in ACC (p < .05; small-volume correction for multiple comparisons). Worsening of performance under levodopa in young subjects and the associated effect on ACC may indicate that overstimulation of the dopaminergic system compromises interference control. This supports the inverted-U-shaped model of neurotransmitter action.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254797     DOI: 10.1162/jocn.2011.21603

Source DB:  PubMed          Journal:  J Cogn Neurosci        ISSN: 0898-929X            Impact factor:   3.225


  9 in total

1.  Levodopa impairs probabilistic reversal learning in healthy young adults.

Authors:  Andrew Vo; Ken N Seergobin; Sarah A Morrow; Penny A MacDonald
Journal:  Psychopharmacology (Berl)       Date:  2016-05-30       Impact factor: 4.530

2.  Correspondence of executive function related functional and anatomical alterations in aging brain.

Authors:  Xin Di; Bart Rypma; Bharat B Biswal
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-09-12       Impact factor: 5.067

3.  Spatial task-related brain activity and its association with preferred and fast pace gait speed in older adults.

Authors:  Joaquin U Gonzales; Kareem Al-Khalil; Michael O'Boyle
Journal:  Neurosci Lett       Date:  2019-10-01       Impact factor: 3.046

4.  Acute khat use reduces response conflict in habitual users.

Authors:  Lorenza S Colzato; Roberta Sellaro; Manuel J Ruiz; Katarzyna Sikora; Bernhard Hommel
Journal:  Front Hum Neurosci       Date:  2013-06-19       Impact factor: 3.169

5.  Aging and response interference across sensory modalities.

Authors:  Maria J S Guerreiro; Jos J Adam; Pascal W M Van Gerven
Journal:  Psychon Bull Rev       Date:  2014-06

6.  Learning real-life cognitive abilities in a novel 360°-virtual reality supermarket: a neuropsychological study of healthy participants and patients with epilepsy.

Authors:  Philip Grewe; Agnes Kohsik; David Flentge; Eugen Dyck; Mario Botsch; York Winter; Hans J Markowitsch; Christian G Bien; Martina Piefke
Journal:  J Neuroeng Rehabil       Date:  2013-04-23       Impact factor: 4.262

7.  Effects of L-dopa during auditory instrumental learning in humans.

Authors:  Tina Weis; Sebastian Puschmann; Andre Brechmann; Christiane M Thiel
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

8.  Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease.

Authors:  Xiuhua Li; Laney Redus; Cang Chen; Paul A Martinez; Randy Strong; Senlin Li; Jason C O'Connor
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

9.  Assaying the effect of levodopa on the evaluation of risk in healthy humans.

Authors:  Mkael Symmonds; Nicholas D Wright; Elizabeth Fagan; Raymond J Dolan
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.